Trial intelligence / Profile preview

Nebulized Lidocaine for Emergence Agitation in Pediatric Tonsillectomy

NCT07871266Phase 3Not yet recruiting

Sponsor
Assiut University
Start
Nov 2026
Primary completion
Nov 2027
01

Overview

A Phase 3 trial of lidocaine in Emergence agitation (EA), emergence delirium (ED), postoperative pain, sponsored by Assiut University. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

Emergence agitation (EA)emergence delirium (ED)postoperative pain

Beyond the preview

Go deeper on NCT07871266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07871266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call